Autoantibody assay and usage in the control of human disease

Details Autoantibody assay and usage in the control of human disease Autoantibody assay and usage in the control of human disease

A - Human Necessities

61

K

A61K 39/00 (2006.01) A61K 39/395 (2006.01) C07K 14/705 (2006.01) C07K 16/28 (2006.01) G01N 33/564 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2129895

2129895 9315759 PCTABS00024 Methods of assay for and therapeutic use of autoantibodies, specifically anti-thymocyte autoantibody (ATAA). This is a teaching of methods for the assay of autoantibodies and for ATAA use, based upon autoantibody quantity in relation to a target lymphocyte population, for predicting body resistivity/susceptibility to disease and tumors, as well as suggesting protocols for the treatment of various diseases, malignancies and autoimmune reactions. The main thrust of the disclosure is the inventor's thesis that, by altering the amount of autoantibodies (in sera) which regulates the target cell population, diseases and/or malignancies may be eliminated or otherwise controlled.

Affiliated with

Also associated with

Rating

Autoantibody assay and usage in the control of human disease does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Autoantibody assay and usage in the control of human disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Autoantibody assay and usage in the control of human disease will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1404205